During the past decade, Erciyes University Medical Faculty conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 7 clinical trials were completed, i.e. on average, 18.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 6 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Erciyes University Medical Faculty" #1 sponsor was "TC Erciyes University" with 23 trials, followed by "Pfizer" with 6 trials sponsored, "Camurus AB" with 2 trials sponsored, "Celgene" with 2 trials sponsored and "Diskapi Teaching and Research Hospital" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Erciyes University Medical Faculty" #1 collaborator was "CenTrial GmbH" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator, "Klinar CRO" with 1 trials as a collaborator and "Pharmasolutions4U" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Erciyes University Medical Faculty" are "Acromegaly" (4 trials), "Prostate Cancer" (4 trials), "Multiple Myeloma" (3 trials), "Blood Transfusion" (2 trials) and "Hemophilia A" (2 trials). Many other conditions were trialed in "Erciyes University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Erciyes University Medical Faculty" are "Drug" (26 trials), "Other" (10 trials), "Procedure" (7 trials), "Biological" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Blood transfusion" (2 trials), "Bortezomib" (2 trials), "CAM2029 (octreotide subcutaneous depot)" (2 trials) and "CoronaVac" (2 trials). Other intervention names were less common.

The vast majority of trials in "Erciyes University Medical Faculty" are 42 trials for "All" genders, 7 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Erciyes University Medical Faculty". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Erciyes University Medical Faculty, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Erciyes University Medical Faculty, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 11 trials that are defined as “Not Applicable".